Obtained data showed that using next-generation imaging with [68Ga]Ga-prostate-specific membrane antigen-11 Positron Emission Tomography/Computed Tomography might favourably impact the oncological outcome of oligometastatic prostate cancer patients treated with metastases-directed therapy. Here, FOLH1 is linked to prostate carcinoma.